Preoperative TNM evaluation of peripheral clinical stage I small cell lung cancer treated by initial lobectomy with adjuvant chemotherapy

Mitsuaki Sakai, Shigemi Ishikawa, Tatsuo Yamamoto, Masataka Onizuka, Yuzuru Sakakibara, Tatsuo Iijima, Masayuki Noguchi, Francesco Petrella

Research output: Contribution to journalArticle

Abstract

Surgery with chemotherapy has been the accepted procedure for treating pathological stage I small cell lung cancer. However, there is a question of whether all clinical stage I patients should undergo surgery or not because of discrepancies between clinical and pathological staging. We conducted a retrospective analysis of TNM evaluation and postoperative survival on 10 clinical stage IA (T1N0M0) and 6 stage IB (T2N0M0) patients who had undergone initial lobectomy followed by chemotherapy. Clinical stage IB showed a high incidence of hilar or mediastinal lymph node involvement than stage IA (P=0.04). The accuracy of the T-factor did not differ between both stages. The pathological mean dimension of primary tumors with lymph node metastasis (33.4 mm) was significantly larger than that without metastasis (22.1 mm) (P=0.04). The difference in survival between clinical stage IA (7 of 10) and stage IB (2 of 6) was large but not significant (P=0.07). Four patients in each clinical stage died of cancer relapses. When indicating surgery for clinical stage I small cell lung cancer, it should be taken into account that primary tumors of more than 30 mm in diameter may suggest the possibility of stages more advanced than pathological stage II because of a high incidence of lymph node metastasis.

Original languageEnglish
Pages (from-to)118-122
Number of pages5
JournalInteractive Cardiovascular and Thoracic Surgery
Volume4
Issue number2
DOIs
Publication statusPublished - Apr 1 2005

Fingerprint

Small Cell Lung Carcinoma
Adjuvant Chemotherapy
Lymph Nodes
Neoplasm Metastasis
Drug Therapy
Neoplasms
Survival
Incidence
Recurrence

Keywords

  • Lymph nodes metastasis
  • Preoperative diagnosis
  • Small cell lung cancer
  • TNM staging

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pulmonary and Respiratory Medicine
  • Surgery

Cite this

Preoperative TNM evaluation of peripheral clinical stage I small cell lung cancer treated by initial lobectomy with adjuvant chemotherapy. / Sakai, Mitsuaki; Ishikawa, Shigemi; Yamamoto, Tatsuo; Onizuka, Masataka; Sakakibara, Yuzuru; Iijima, Tatsuo; Noguchi, Masayuki; Petrella, Francesco.

In: Interactive Cardiovascular and Thoracic Surgery, Vol. 4, No. 2, 01.04.2005, p. 118-122.

Research output: Contribution to journalArticle

Sakai, Mitsuaki ; Ishikawa, Shigemi ; Yamamoto, Tatsuo ; Onizuka, Masataka ; Sakakibara, Yuzuru ; Iijima, Tatsuo ; Noguchi, Masayuki ; Petrella, Francesco. / Preoperative TNM evaluation of peripheral clinical stage I small cell lung cancer treated by initial lobectomy with adjuvant chemotherapy. In: Interactive Cardiovascular and Thoracic Surgery. 2005 ; Vol. 4, No. 2. pp. 118-122.
@article{124cd69ebcf84e79b82924b7ef0f0b51,
title = "Preoperative TNM evaluation of peripheral clinical stage I small cell lung cancer treated by initial lobectomy with adjuvant chemotherapy",
abstract = "Surgery with chemotherapy has been the accepted procedure for treating pathological stage I small cell lung cancer. However, there is a question of whether all clinical stage I patients should undergo surgery or not because of discrepancies between clinical and pathological staging. We conducted a retrospective analysis of TNM evaluation and postoperative survival on 10 clinical stage IA (T1N0M0) and 6 stage IB (T2N0M0) patients who had undergone initial lobectomy followed by chemotherapy. Clinical stage IB showed a high incidence of hilar or mediastinal lymph node involvement than stage IA (P=0.04). The accuracy of the T-factor did not differ between both stages. The pathological mean dimension of primary tumors with lymph node metastasis (33.4 mm) was significantly larger than that without metastasis (22.1 mm) (P=0.04). The difference in survival between clinical stage IA (7 of 10) and stage IB (2 of 6) was large but not significant (P=0.07). Four patients in each clinical stage died of cancer relapses. When indicating surgery for clinical stage I small cell lung cancer, it should be taken into account that primary tumors of more than 30 mm in diameter may suggest the possibility of stages more advanced than pathological stage II because of a high incidence of lymph node metastasis.",
keywords = "Lymph nodes metastasis, Preoperative diagnosis, Small cell lung cancer, TNM staging",
author = "Mitsuaki Sakai and Shigemi Ishikawa and Tatsuo Yamamoto and Masataka Onizuka and Yuzuru Sakakibara and Tatsuo Iijima and Masayuki Noguchi and Francesco Petrella",
year = "2005",
month = "4",
day = "1",
doi = "10.1510/icvts.2004.101428",
language = "English",
volume = "4",
pages = "118--122",
journal = "Interactive Cardiovascular and Thoracic Surgery",
issn = "1569-9293",
publisher = "European Association for Cardio-Thoracic Surgery",
number = "2",

}

TY - JOUR

T1 - Preoperative TNM evaluation of peripheral clinical stage I small cell lung cancer treated by initial lobectomy with adjuvant chemotherapy

AU - Sakai, Mitsuaki

AU - Ishikawa, Shigemi

AU - Yamamoto, Tatsuo

AU - Onizuka, Masataka

AU - Sakakibara, Yuzuru

AU - Iijima, Tatsuo

AU - Noguchi, Masayuki

AU - Petrella, Francesco

PY - 2005/4/1

Y1 - 2005/4/1

N2 - Surgery with chemotherapy has been the accepted procedure for treating pathological stage I small cell lung cancer. However, there is a question of whether all clinical stage I patients should undergo surgery or not because of discrepancies between clinical and pathological staging. We conducted a retrospective analysis of TNM evaluation and postoperative survival on 10 clinical stage IA (T1N0M0) and 6 stage IB (T2N0M0) patients who had undergone initial lobectomy followed by chemotherapy. Clinical stage IB showed a high incidence of hilar or mediastinal lymph node involvement than stage IA (P=0.04). The accuracy of the T-factor did not differ between both stages. The pathological mean dimension of primary tumors with lymph node metastasis (33.4 mm) was significantly larger than that without metastasis (22.1 mm) (P=0.04). The difference in survival between clinical stage IA (7 of 10) and stage IB (2 of 6) was large but not significant (P=0.07). Four patients in each clinical stage died of cancer relapses. When indicating surgery for clinical stage I small cell lung cancer, it should be taken into account that primary tumors of more than 30 mm in diameter may suggest the possibility of stages more advanced than pathological stage II because of a high incidence of lymph node metastasis.

AB - Surgery with chemotherapy has been the accepted procedure for treating pathological stage I small cell lung cancer. However, there is a question of whether all clinical stage I patients should undergo surgery or not because of discrepancies between clinical and pathological staging. We conducted a retrospective analysis of TNM evaluation and postoperative survival on 10 clinical stage IA (T1N0M0) and 6 stage IB (T2N0M0) patients who had undergone initial lobectomy followed by chemotherapy. Clinical stage IB showed a high incidence of hilar or mediastinal lymph node involvement than stage IA (P=0.04). The accuracy of the T-factor did not differ between both stages. The pathological mean dimension of primary tumors with lymph node metastasis (33.4 mm) was significantly larger than that without metastasis (22.1 mm) (P=0.04). The difference in survival between clinical stage IA (7 of 10) and stage IB (2 of 6) was large but not significant (P=0.07). Four patients in each clinical stage died of cancer relapses. When indicating surgery for clinical stage I small cell lung cancer, it should be taken into account that primary tumors of more than 30 mm in diameter may suggest the possibility of stages more advanced than pathological stage II because of a high incidence of lymph node metastasis.

KW - Lymph nodes metastasis

KW - Preoperative diagnosis

KW - Small cell lung cancer

KW - TNM staging

UR - http://www.scopus.com/inward/record.url?scp=24744466517&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24744466517&partnerID=8YFLogxK

U2 - 10.1510/icvts.2004.101428

DO - 10.1510/icvts.2004.101428

M3 - Article

C2 - 17670370

AN - SCOPUS:24744466517

VL - 4

SP - 118

EP - 122

JO - Interactive Cardiovascular and Thoracic Surgery

JF - Interactive Cardiovascular and Thoracic Surgery

SN - 1569-9293

IS - 2

ER -